Pharmaceutical News

RSS

Leading UK Engineering Firm adi Group Launches Ground-Breaking New Life Sciences Division

To directly support the requirements of the Pharmaceutical and Life Sciences industry, adi Group, a leading engineering firm based in the UK, has launched its new Life Sciences division.

25 Jul 2023

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine.

6 Jun 2023

LLNL set off to develop vaccines to treat rheumatoid arthritis and lupus

People afflicted with autoimmune diseases may someday receive help through treatments now under development by a Lawrence Livermore National Laboratory (LLNL) licensee and its' collaborations with two major pharmaceutical companies.

19 Feb 2023

Promotional spending share allocated to consumer advertising higher for drugs with low added benefit

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to consumer advertising was on average 14.3 percentage points higher for drugs with low added benefit compared to drugs with high added benefit.

8 Feb 2023

Plankton could hold key for understanding link between ocean pollution and human health

Plankton may offer a way to monitor historical marine pollution trends, and could be used to predict trends in human health, according to new research.

10 Jan 2023

Orbit Discovery awarded Innovate UK grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

Orbit Discovery Ltd., (“Orbit”) a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, has been awarded a Smart grant by Innovate UK, the UK’s innovation agency.

From Orbit Discovery 14 Jun 2022

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

VectorBuilder Inc. has announced the construction of a new R&D and manufacturing center in Guangzhou, China.

From VectorBuilder 12 Apr 2022

Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research

Rigaku is proud to be hosting the inaugural Pharma Forum, a free-to-attend, two-day virtual event from April 27-28, 2022. The forum examines a range of analytical techniques and how these can be applied during the development, formulation, and manufacture of pharmaceuticals.

From Rigaku Corporation 4 Apr 2022

Ziath sample management innovation at Analytica 2022

Ziath has chosen Analytica 2022 in Munich, Germany (21-24th June) to launch two new innovative sample management products - Handheld 3 and LUX.

From Ziath Ltd 3 Mar 2022

Process-scale chromatography bed supports

Porvair Sciences high performance, precision manufactured Vyon® porous plastics are perfect support materials for chromatographic resins used in the isolation and purification steps of pharmaceutical drug and vaccine production.

From Porvair Sciences Limited 9 Feb 2022

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical computing.

From TetraScience, Inc. 18 Jan 2022

A folic acid-like drug changes a DNA process within brain tumors

A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent glioblastoma, changed aDNA process within their brain tumors, according to results from a phase 1 clinical trial.

From Vanderbilt University 6 Jan 2022

Waters BioAccord System with ACQUITY Premier brings greater simplicity, accuracy and reproducibility to multi-attribute monitoring of biopharmaceuticals

Waters Corporation today introduced the Waters™ BioAccord™ System with ACQUITY™ Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC™ with MaxPeak™ High Performance Surface technology.

From Waters Corporation 17 Sep 2021

Expert warns people on the intake of livestock deworming drug to treat COVID-19

Rutgers Professor Lewis Nelson is available to discuss the dangers of people taking the livestock deworming drug ivermectin to try to treat COVID-19.

1 Sep 2021

New iron-nitrogen-doped carbon catalyst could reduce harmful air pollutants

Our reliance on fossil fuels as a primary energy source has pushed air pollution to an all-time high, resulting in several environmental and health concerns. Among the major pollutants, nitrogen oxide (NOx) accumulation can cause severe respiratory diseases and imbalance in the Earth's nitrogen cycle. Reducing NOx accumulation is, therefore, an issue of utmost importance.

21 May 2021

Researchers demonstrate potential preventive treatment for Crohn's disease

A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease.

22 Dec 2020

Study estimates the cost-effectiveness of esketamine used for treating depression

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.

14 Jul 2020

Single dose of flu drug can limit the spread of the illness within households

A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.

14 Jul 2020

Beta blockers can increase risk of heart failure in women more than men

Women taking beta blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospital with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.

14 Jul 2020

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to a new study by a team from the University of Michigan.

14 Jul 2020

Pharmaceutical News

Leading UK Engineering Firm adi Group Launches Ground-Breaking New Life Sciences Division

Breakthrough: Sequencing Functional Antibody Proteins Directly from Human Blood

LLNL set off to develop vaccines to treat rheumatoid arthritis and lupus

Promotional spending share allocated to consumer advertising higher for drugs with low added benefit

Plankton could hold key for understanding link between ocean pollution and human health

Orbit Discovery awarded Innovate UK grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research

Ziath sample management innovation at Analytica 2022

Process-scale chromatography bed supports

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

A folic acid-like drug changes a DNA process within brain tumors

Waters BioAccord System with ACQUITY Premier brings greater simplicity, accuracy and reproducibility to multi-attribute monitoring of biopharmaceuticals

Expert warns people on the intake of livestock deworming drug to treat COVID-19

New iron-nitrogen-doped carbon catalyst could reduce harmful air pollutants

Researchers demonstrate potential preventive treatment for Crohn's disease

Study estimates the cost-effectiveness of esketamine used for treating depression

Single dose of flu drug can limit the spread of the illness within households

Beta blockers can increase risk of heart failure in women more than men

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics